Bausch Health Companies (BHC) Other Non Operating Income (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Other Non Operating Income came in at -$7.0 million in Q2 2026, down 103.93% year-over-year from $178.0 million in Q2 2025, and up 36.36% quarter-over-quarter from -$11.0 million in Q1 2026.
Analysis
Bausch Health Companies (BHC) Other Non Operating Income (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Other Non Operating Income across 18 years of filings, most recently posting -$7.0 million for Q2 2026.
- In Q2 2026, Other Non Operating Income fell 103.93% year-over-year to -$7.0 million; the TTM figure through Jun 2026 stood at -$44.0 million (down 128.76% YoY), while the FY2025 annual figure was $162.0 million, up 444.68% from the prior year.
- Other Non Operating Income came in at -$7.0 million for Q2 2026 at Bausch Health Companies, up from -$11.0 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $570.0 million in Q3 2022 to a low of -$21.0 million in Q2 2023.
- Average Other Non Operating Income over 5 years is $65.5 million, with a median of -$7.0 million recorded in 2022.
- Year-over-year, Other Non Operating Income jumped 4850.0% in 2022 and tumbled 2200.0% in 2024.
- Over 5 years, Other Non Operating Income stood at $369.0 million in 2022, then tumbled by 99.73% to $1.0 million in 2023, then plunged by 2200.0% to -$21.0 million in 2024, then gained by 9.52% to -$19.0 million in 2025, then jumped by 63.16% to -$7.0 million in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$7.0 million in Q2 2026, -$11.0 million in Q1 2026, and -$19.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.00 Mn |
| Mar 31, 2026 | -11.00 Mn |
| Dec 31, 2025 | -19.00 Mn |
| Sep 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | 178.00 Mn |
| Mar 31, 2025 | -4.00 Mn |
| Dec 31, 2024 | -21.00 Mn |
| Jun 30, 2024 | 12.00 Mn |
| Mar 31, 2024 | -15.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | -7.00 Mn |
| Jun 30, 2023 | -21.00 Mn |
| Mar 31, 2023 | -10.00 Mn |
| Dec 31, 2022 | 369.00 Mn |
| Sep 30, 2022 | 570.00 Mn |
| Jun 30, 2022 | 113.00 Mn |
| Mar 31, 2022 | -7.00 Mn |
| Sep 30, 2021 | -12.00 Mn |
| Jun 30, 2021 | -45.00 Mn |
| Mar 31, 2021 | -5.00 Mn |